Talk:Omalizumab

message: says it binds to receptors then it says it binds to the IgE itself.  i doubt it's both, since they are completely different molecules. Eupedia 22:55, 18 April 2006 (UTC)
replies: text: I am not entirely sure how this drug works, but antibodies are perfectly capable of binding two substrates at once. I slapped an  tag on the page. If we can't find anyone, I'll read the reserach paper and fix it (might have to bug me and remind me though). Isopropyl 05:43, 2 May 2006 (UTC)
replies: text: I believe that it binds to the Fc receptor portion of the IgE antibody molecule.  WhatamIdoing (talk) 04:52, 13 January 2008 (UTC)
thread_title: says

message: Can we give a citation to one or more patents?  If so, when will they expire? -- Beland 23:39, 31 July 2007 (UTC)
thread_title:  Patent status 

message: External links to patient support groups (especially online chat boards) and blogs are normally not accepted on Wikipedia.  Please read the external links policy and the specific rules for medical articles before adding more external links.  WhatamIdoing (talk) 04:49, 13 January 2008 (UTC)
thread_title: External links

message: The article claims that Automation and filtration techniques are considered complicated and bring up the cost of the drug.  This may have been true in 1993, but now these techniques are standard practice and rather well understood.  Moreover, the actual technique is not very different than the way Budweiser is brewed, but Bud only goes for about $1 a bottle.  Further, the development of such process techniques (even then) generally pales in comparison to drug discovery.  
It seems much more likely that the current price structure is almost entirely a result of self made Monopoly the joint venture has given all companies involved and should have been disallowed due to anti-trust reasons.  If the venture had not formed, I'd imagine there's be a price-fixing law suit.  —Preceding unsigned comment added by 65.244.16.254 (talk) 03:49, 22 April 2010 (UTC)
thread_title:  Cost excuses 

message: This needs clearing up: was there a statistically significant difference in the rate of cancer in placebo vs omalizumab or is the author trying to say that the increased risk is not clinically important? If it is the first, I would argue that it is then not a side effect because there was no certainty that the increase in cancer to the treatment group was not due to random chance. If it is the latter, this statement is misleading as a patient's risk for cancer nearly doubles. Sure it is still only a 0.5% overall, but this is not the right of the author to assert his/her opinion. This is wikipedia. This is not wikiopinia.  — Preceding unsigned comment added by 204.69.132.129 (talk) 18:26, 25 October 2011 (UTC)
replies: text: Clarified the wording. --Doc James (talk · contribs · email) 19:24, 3 December 2011 (UTC)
thread_title:  "Not significant" side effect of omalizumab is cancer 

message: This addition appears speculative, based on an interpretation of events that is not supported by reliable sources. The editor making this addition is new, and might think that linking to the patents represents reliable sourcing; however, it is the interpretation of events that needs sourcing. I've reverted once but it was immediately restored and I will not edit war over this. -- Scray (talk) 11:07, 29 June 2013 (UTC)
replies: text: Because this article is within scope of WP:WPMED, I have placed a notice there inviting further input. -- Scray (talk) 15:26, 30 June 2013 (UTC)
replies: text: I'd like first to comment that this has turned into quite a good article on the whole, due almost entirely to the work of PeaceRock.  But that being said, I agree that the passage in question needs a better source than a couple of patent applications, and have returned the article to Scray's version.  I think it would be a shame to get into a serious dispute about such a minor issue, though. Looie496 (talk) 15:38, 30 June 2013 (UTC)
replies: text: I agree with what has been said and with Loooie's recent edit. Thanks to PeaceRock for your work. Biosthmors (talk) 15:59, 30 June 2013 (UTC)
replies: text: What source is the basis for the statement, "", which is the first sentence of this edit?  -- Scray (talk) 00:30, 1 July 2013 (UTC)
thread_title:  Addition to History section regarding patents 

message: Perusing the History section again, it mentions Tanox a dozen times in this article about a product made by a different company. The section contains multiple claims that are poorly sourced. Is tagging enough, or should we remove the section's content to allow time for proper sourcing and balance?  -- Scray (talk) 01:21, 5 July 2013 (UTC)
replies: text: The anti-IgE approach stated in Tanox many years before the omalizumab program. The evolution of the anti-IgE program and omalizumab has an interesting history. It also involved a long partnership between Tanox and Novartis and Genentech. References and citations have been provided for most of the statements in History and in other sections. I think that the article is much improved and more complete as a reference for readers on the topic of omalizumab, which many people refer to as anti-IgE therapy. Please examine the editing and remove the warning sign at the top of the article.PeaceRock (talk) 03:08, 8 July 2013 (UTC)

text: About half of this article does not seem specific to Omalizumab and perhaps could be [re]moved to an anti-IgE therapy article or similar ?  Sadly at the moment anti-IgE therapy just redirects to this omalizumab. - Rod57 (talk) 22:24, 17 October 2014 (UTC)
thread_title:  More on the History section 

message: Removed estimated pricing from article. Citation for price was from a sponsored link. Actual cost for the drug depends on individual insurance, dosages, and other variables thus we shouldn't speculate.  — Preceding unsigned comment added by Eacon (talk • contribs) 02:53, 22 December 2013 (UTC)
thread_title:  Price 

message: The introduction reads like an advertisement and makes me wonder about the source of the intro and its biases. — Preceding unsigned comment added by 205.250.86.194‎ (talk • contribs) 15:42, 1 August 2018‎(UTC)
:I've done some trimming.  needs a lot more work. thanks for pointing  it out. Jytdog (talk) 16:32, 1 August 2018 (UTC)
thread_title: Promotional